A Patient with Non-Hodgkin Lymphoma and Nonspecific Interstitial Pneumonia during Ibrutinib Therapy
We present a 74-year-old male with nonspecific interstitial pneumonia (NSIP) during treatment with ibrutinib for mantle cell lymphoma. Previously, the patient had received six cycles of bendamustine and rituximab and six cycles of R-CHOP, followed by rituximab maintenance therapy. Respiratory tract...
Saved in:
| Main Authors: | Sven Jungmann, Wolf-Dieter Ludwig, Nicolas Schönfeld, Torsten-Gerriet Blum, Claudia Großwendt, Christian Boch, Beate Rehbock, Sergej Griff, Alexander Schmittel, Torsten T. Bauer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2017/5640186 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diffuse Alveolar Hemorrhage Associated with Epithelioid Angiosarcoma of the Lung: A Challenging Diagnosis
by: Felix Wuest, et al.
Published: (2023-01-01) -
Severe Nonspecific Interstitial Pneumonia (NSIP) in an Adolescent
by: Giuliana Cerro Chiang, et al.
Published: (2022-01-01) -
Approaches to the prevention and therapy of ibrutinib-associated bleeding in adult patients
by: E. V. Volchkov, et al.
Published: (2018-10-01) -
Antithrombotic Therapy in Patients with Malignant Lymphoproliferative Disorders Treated with Ibrutinib
by: EI Emelina, et al.
Published: (2019-09-01) -
Ibrutinib as treatment for Bing–Neel syndrome reclassified as glioblastoma: a case report
by: Charlotte Dahl Gravesen, et al.
Published: (2024-09-01)